Healthcare ❯Pharmaceuticals

Vaccines

RSV Vaccine Covid-19 Vaccine COVID-19 Vaccines HPV Vaccine Specific Vaccines COVID-19 Vaccine Sales Decline Covid-19 Vaccines Combination Vaccines Mpox Vaccine COVID-19 Covid-19 AstraZeneca Covid Vaccine Covid Vaccine Gardasil Safety Vaccine Efficacy Safety Data

Merck Stock Declines After Weak 2025 Guidance Despite Strong Q4 Results

The pharmaceutical giant exceeded Q4 revenue and earnings estimates but disappointed investors with a muted outlook for the year ahead.

Merck Cuts 2025 Revenue Forecast After Halting Gardasil Shipments to China

Moderna Cuts 2025 Revenue Forecast by $1 Billion, Shares Drop Over 20%

Novavax Shares Fall as Revenue Forecast Slashed Again

Moderna Reports Unexpected Profit on Strong COVID Vaccine Sales

GSK Faces Revenue Decline Amid Vaccine Sales Slump

Novavax Lowers 2024 Revenue Forecast, Reduces European Operations

CDC Updates RSV Vaccine Guidance for Older Adults

FDA Approves Moderna's mRNA RSV Vaccine for Older Adults

Sanofi and Novavax Forge Major Alliance, Boosting Novavax's Market Position

Moderna Suspends Construction of Vaccine Plant in Kenya Due to Low Demand